ENULOSE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Enulose, and what generic alternatives are available?
Enulose is a drug marketed by Actavis Mid Atlantic and is included in one NDA.
The generic ingredient in ENULOSE is lactulose. There are twenty drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the lactulose profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Enulose
A generic version of ENULOSE was approved as lactulose by HIKMA on July 3rd, 1995.
Summary for ENULOSE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 28 |
Clinical Trials: | 1 |
Patent Applications: | 3,641 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for ENULOSE |
DailyMed Link: | ENULOSE at DailyMed |
Recent Clinical Trials for ENULOSE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Tampa General Hospital | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for ENULOSE
US Patents and Regulatory Information for ENULOSE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Actavis Mid Atlantic | ENULOSE | lactulose | SOLUTION;ORAL, RECTAL | 071548-001 | Aug 15, 1988 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |